|
Real-time
Euronext Amsterdam
03:22:17 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 70.70 EUR | +1.14% |
|
+0.28% | -2.35% |
| 08-11 | Philips, Exor Agree to Raise Stakeholding Cap to 22% | MT |
| 08-11 | Agnelli family's Exor can raise Philips stake to 22% under updated agreement | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 32.93B | 40.94B | 43.44B | - | - | |||||
Finance Div. Revenues | 685M | 909M | 1.3B | - | - | |||||
Insurance Division Revenues | - | - | - | - | - | |||||
Gain (Loss) on Sale of Investment, Total (Rev) | - | - | - | 14.26B | -4.3B | |||||
Interest And Invest. Income (Rev) | - | - | - | 1.14B | 781M | |||||
Total Revenues | 33.62B | 41.84B | 44.74B | 15.4B | -3.52B | |||||
Cost of Goods Sold, Total | 25.65B | 31.72B | 32.27B | - | - | |||||
Insurance Division Operating Expenses, Total | 7M | - | - | - | - | |||||
Interest Expense - Finance Division | 324M | 624M | 1.16B | - | - | |||||
Gross Profit | 7.64B | 9.5B | 11.31B | 15.4B | -3.52B | |||||
Selling General & Admin Expenses, Total | 2.68B | 3.32B | 3.55B | 58M | 81M | |||||
R&D Expenses | 1.81B | 2.07B | 2.47B | - | - | |||||
Other Operating Expenses | - | - | - | - | -2M | |||||
Other Operating Expenses, Total | 4.49B | 5.39B | 6.02B | 58M | 79M | |||||
Operating Income | 3.15B | 4.11B | 5.29B | 15.34B | -3.6B | |||||
Interest Expense, Total | -191M | -982M | -1.69B | -113M | -100M | |||||
Interest And Investment Income | 2.11B | 2.72B | 3.37B | 37M | 47M | |||||
Net Interest Expenses | 1.92B | 1.74B | 1.68B | -76M | -53M | |||||
Income (Loss) On Equity Invest. | - | - | - | - | - | |||||
Currency Exchange Gains (Loss) | - | - | - | 4M | -49M | |||||
Other Non Operating Income (Expenses) | -100M | 37M | 1.02B | -129M | 18M | |||||
EBT, Excl. Unusual Items | 4.97B | 5.89B | 7.99B | 15.14B | -3.68B | |||||
Restructuring Charges | -72M | -55M | -106M | - | - | |||||
Merger & Related Restructuring Charges | -48M | - | -43M | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | 10M | 29M | - | - | |||||
Gain (Loss) On Sale Of Assets | - | 93M | - | - | - | |||||
Asset Writedown | -16M | -15M | - | - | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | -179M | -24M | - | -374M | -14M | |||||
EBT, Incl. Unusual Items | 4.65B | 5.9B | 7.87B | 14.76B | -3.7B | |||||
Income Tax Expense | 1.3B | 1.06B | 1.1B | 91M | 98M | |||||
Earnings From Continuing Operations | 3.35B | 4.84B | 6.78B | 14.67B | -3.79B | |||||
Earnings Of Discontinued Operations | 104M | 1.37B | - | - | - | |||||
Net Income to Company | 3.45B | 6.2B | 6.78B | 14.67B | -3.79B | |||||
Minority Interest | -1.74B | -1.98B | -2.58B | - | - | |||||
Net Income - (IS) | 1.72B | 4.23B | 4.19B | 14.67B | -3.79B | |||||
Net Income to Common Incl Extra Items | 1.72B | 4.23B | 4.19B | 14.67B | -3.79B | |||||
Net Income to Common Excl. Extra Items | 1.61B | 2.86B | 4.19B | 14.67B | -3.79B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 7.8 | 18.38 | 18.72 | 68.27 | -18.48 | |||||
Basic EPS - Continuing Operations | 7.33 | 12.43 | 18.72 | 68.27 | -18.48 | |||||
Basic Weighted Average Shares Outstanding | 220M | 230M | 224M | 215M | 205M | |||||
Net EPS - Diluted | 7.79 | 18.1 | 18.38 | 67 | -18.48 | |||||
Diluted EPS - Continuing Operations | 7.32 | 12.25 | 18.38 | 67 | -18.48 | |||||
Diluted Weighted Average Shares Outstanding | 220M | 233M | 228M | 219M | 205M | |||||
Normalized Basic EPS | 6.21 | 7.4 | 10.77 | 44.02 | -11.21 | |||||
Normalized Diluted EPS | 6.21 | 7.3 | 10.6 | 43.2 | -11.21 | |||||
Dividend Per Share | 0.43 | 0.44 | 0.46 | 0.49 | 0.49 | |||||
Payout Ratio | 26.5 | 14.22 | 17.07 | 0.67 | -2.45 | |||||
Supplemental Items | ||||||||||
EBITDA | 4.06B | 5.15B | 6.43B | 17.39B | - | |||||
EBITA | 3.51B | 4.46B | 5.65B | 15.34B | -3.6B | |||||
EBIT | 3.15B | 4.11B | 5.29B | 15.34B | -3.6B | |||||
EBITDAR | 4.06B | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 27.99 | 17.98 | 13.91 | 0.62 | -2.65 | |||||
Total Current Taxes | 751M | 1.19B | 1.58B | 29M | 63M | |||||
Total Deferred Taxes | -217M | -101M | -479M | 62M | -40M | |||||
Normalized Net Income | 1.37B | 1.7B | 2.41B | 9.46B | -2.3B | |||||
Interest on Long-Term Debt | 470M | 254M | 230M | 107M | 97M | |||||
Non-Cash Pension Expense | 6M | 8M | 28M | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | - | - | - | 58M | 57M | |||||
Research And Development Expense From Footnotes | 2.07B | 2.09B | 2.47B | - | - | |||||
Net Rental Expense, Total | 8M | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | 287K | - | - | - | - | |||||
Imputed Operating Lease Depreciation | 7.71M | - | - | - | - | |||||
Stock-Based Comp., G&A Exp. (Total) | - | - | - | 8M | 12M | |||||
Stock-Based Comp., Other (Total) | 275M | 250M | 17M | 16M | 14M | |||||
Total Stock-Based Compensation | 275M | 250M | 17M | 24M | 26M |
- Stock Market
- Stocks
- EXO Stock
- Financials Exor N.V.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















